Persistent shortages of medicines remain one of the most widely reported challenges within the Maldives’ healthcare system, prompting renewed government efforts to improve supply management and access across the country.
The State Pharmaceutical and Medical Supply Corporation, established in 2025, has been tasked with addressing these gaps through structural and administrative reforms. According to comments made by its Managing Director, Dr Shah Mahir, on a programme aired by state media, resolving the issue will require more than increased procurement, with a stronger focus on systems that track and manage availability nationwide.
A key constraint identified is the absence of a centralised platform to monitor pharmaceutical stocks. Without such a system, healthcare providers face difficulties in assessing availability, tracking expiration dates, and identifying usage patterns, particularly for high-risk medicines. This has limited the ability of authorities to anticipate shortages and respond in a timely manner.
Efforts are now underway to develop a national digital system that would consolidate information on medicine availability and distribution. The proposed platform is expected to provide visibility on stock levels and locations, while also supporting longer-term planning by generating data on demand and usage trends.
In parallel, the Corporation has initiated its first procurement order as part of its mandate to improve supply flows. A dedicated hotline has also been introduced, allowing the public to raise concerns and make enquiries regarding the availability of medicines.
While these steps signal an attempt to address long-standing supply issues, the effectiveness of the approach will depend on how quickly digital infrastructure can be implemented and integrated across the healthcare system.
